<DOC>
	<DOCNO>NCT01973673</DOCNO>
	<brief_summary>Prostate cancer patient receive hormone treatment ( androgen deprivation therapy , ADT ) increase risk develop bone loss osteoporosis side effect . To prevent , guideline recommend participation healthy bone behaviours include weight-bearing exercise adequate calcium/vitamin D intake . However , prior study show patient regularly screen counselled regard healthy bone behaviour receive ADT . Maintaining bone health prostate cancer patient important men ADT increase risk fracture . In study , investigator examine whether intervention design improve healthy bone behaviour among prostate cancer patient ADT implement . The intervention consist write `` healthy bone prescription '' , brief verbal counseling , print educational material participant . Investigators hope obtain initial estimate whether intervention work . They also hope show simple intervention implement real , work cancer clinic . The investigator hypothesize intervention improve bone health prostate cancer patient receive ADT ( healthy bone prescription , verbal counseling , print educational material ) effective , implementable , accepted clinician patient .</brief_summary>
	<brief_title>Healthy Bones Study</brief_title>
	<detailed_description>The study before-and-after design , allow comparison intervention implementation implementation . This design permit reliable assessment baseline characteristic prior implementation intervention time , particularly situation randomization feasible ( e.g . due contamination treat physician ) . The point intervention start deliver new study participant 150 patient accrue Before arm . 1 . Before/control arm ( Before arm ) Usual care Princess Margaret Cancer Centre ( PM ) oncologist . 2 . After/intervention arm ( After arm ) Provision healthy bone prescription , verbal counselling , write educational material regard healthy bone behaviour PM oncologist delegate ( e.g . clinical fellow ) , addition usual care oncologist . The intervention may deliver subsequent follow-up request patient and/or discretion oncologist .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Prostate cancer patient receive ADT study entry ( maximum 12 month prior study entry plan receive ADT within 3 week study entry ) , expect duration &gt; 6 month ; Eastern Cooperative Oncology Group ( ECOG ) performance status &lt; 3 Unable exercise ( e.g . major physical disability , severe osteoarthritis , severe comorbidity ) ; severe cardiac disease ( congestive heart failure New York Heart Association ( NYHA ) class &gt; 2 , angioplasty/coronary artery bypass surgery within 3 month study entry ) ; patient bone endocrinopathy ( parathyroid disorder , osteomalacia ) ; stage IVV chronic kidney disease ( estimate glomerular filtration rate [ eGFR ] &lt; 30 mL/min/1.75 m2 ; prior serum creatinine require entry study ) ; allergy component calcium &amp; vitamin D tablet .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>prostate cancer</keyword>
	<keyword>ADT</keyword>
	<keyword>bone health</keyword>
</DOC>